Effect of early antibiotic treatment on the antibody response to cytoplasmic proteins of Brucella melitensis in mice
- PMID: 10225853
- PMCID: PMC103740
- DOI: 10.1128/CDLI.6.3.440-443.1999
Effect of early antibiotic treatment on the antibody response to cytoplasmic proteins of Brucella melitensis in mice
Abstract
To test whether antibiotic therapy hampers the antibody response to Brucella antigens, 30 BALB/c mice were infected with Brucella melitensis H38 and randomized for treatment with doxycycline administered intraperitoneally for 42 days starting at 7 or 28 days postinfection (p.i.) (groups DOX7 and DOX28, respectively) or for no treatment (control group). Antibodies to smooth lipopolysaccharide (LPS) reached peak levels (mean optical density [OD] = 2.618) between days 56 and 70 p.i. in the control group, and similar peak levels (mean OD = 2.486) were observed in the DOX28 group, but significantly lower peak levels (mean OD = 0.821) were observed at 28 days p.i. in the DOX7 group. The antibody response against cytoplasmic proteins depleted of LPS (CPs) reached maximal levels (mean OD = 2.402) between days 56 and 70 p.i. in the control group, but no response was detected in the DOX7 group. Anti-CP antibodies were detected in only three animals from the DOX28 group, at levels significantly lower than those in the control group (mean maximal OD = 0.791). The pattern of antibody response to an 18-kDa cytoplasmic protein of Brucella spp. was similar to that against the CP antigen. This study shows that early antibiotic treatment affects the antibody response of mice to cytoplasmic proteins of Brucella and, to a lesser extent, to LPS.
Figures
References
-
- Ariza J, Corredoira J, Pallarés R, Viladrich P F, Rufi G, Pujol M, Gudiol F. Characteristics of and risk factors for relapse of brucellosis in humans. Clin Infect Dis. 1995;20:1241–1249. - PubMed
-
- Baldi P C, Miguel S E, Fossati C A, Wallach J C. Serological follow-up of human brucellosis by measuring IgG antibodies directed to S-LPS and cytoplasmic proteins of Brucella. Clin Infect Dis. 1996;22:446–455. - PubMed
-
- Baldi, P. C., G. H. Giambartolomei, J. C. Wallach, C. A. Velikovsky, and C. A. Fossati. Different patterns of antibody response to lipopolysaccharide and cytoplasmic proteins of Brucella in human brucellosis of recent onset. Submitted for publication.
-
- Cloeckaert A, Debbarh H S, Zygmunt M S, Dubray G. Production and characterisation of monoclonal antibodies to Brucella melitensis cytosoluble proteins that are able to differentiate antibody responses of infected sheep from Rev. 1 vaccinated sheep. J Med Microbiol. 1996;45:206–213. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
